MCF, Y., RA, L., & CR, A. (2026). Recurrent Epidermal Growth Factor Receptor 2 (ERBB2) Mutations Drive the Pathogenesis of Multifocal Neurofibroma Variants. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 39(5), 100992. https://doi.org/10.1016/j.modpat.2026.100992
Chicago Style (17th ed.) CitationMCF, Yeung, Lefkowitz RA, and Antonescu CR. "Recurrent Epidermal Growth Factor Receptor 2 (ERBB2) Mutations Drive the Pathogenesis of Multifocal Neurofibroma Variants." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 39, no. 5 (2026): 100992. https://doi.org/10.1016/j.modpat.2026.100992.
MLA (9th ed.) CitationMCF, Yeung, et al. "Recurrent Epidermal Growth Factor Receptor 2 (ERBB2) Mutations Drive the Pathogenesis of Multifocal Neurofibroma Variants." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 39, no. 5, 2026, p. 100992, https://doi.org/10.1016/j.modpat.2026.100992.